At a glance
CDC works with partners in South Sudan to strengthen the country's public health and clinical systems. CDC delivers quality HIV testing and treatment services and responds to emerging public health threats.
Background
CDC collaborates with the South Sudan Ministry of Health (MOH) and other partners to strengthen the country's health system. Other partners include the National AIDS Commission and the Global Fund to Fight AIDS, Tuberculosis, and Malaria. This is achieved by providing resources and technical assistance in adult and pediatric HIV treatment and HIV/tuberculosis (TB) screening activities. In addition, efforts include prevention of mother-to-child transmission (PMTCT) for all pregnant and lactating women who are living with HIV. Other efforts include targeted prevention programming, laboratory strengthening, blood safety, and enhancing health information systems.
CDC also supports in strengthening the health system by operationalizing the National Public Health Laboratory and National Blood Transfusion Center services. Other supported efforts include quality assurance and accreditation programs. CDC also supports enhancing national HIV surveillance systems as well as health and laboratory management information systems.
Download CDC South Sudan's Fact Sheet
HIV and TB data
HIV/AIDS
Estimated HIV Prevalence (Ages 15-49)
Estimated AIDS Deaths (Age≥15)
Estimated Orphans Due to AIDS
Reported Number Receiving Antiretroviral Therapy (Age≥15)
Tuberculosis (TB)
Estimated TB Incidence
TB Patients with Known HIV-Status who are HIV-Positive
TB Treatment Success Rate
Key activities and accomplishments
Sustained health services
CDC implementing partners provide HIV testing and treatment support across the greater equatorial region and Lakes State. PEPFAR data for Fiscal Year (FY) 2022 indicates CDC directly supported 35,782 people living with HIV (PLHIV) on antiretroviral therapy (ART). This accounted for more than two-thirds (68 percent) of PLHIV on ART nationally. CDC partners initiated 8,447 new PLHIV on ART. This was more than half (54 percent) of the 15,437 new ART initiations in the same period nationally.
CDC provides the MOH with critical support to expand in-country viral load (VL) testing for those on ART. In FY 2022, 70 percent of PLHIV eligible for VL testing were tested (30,586) in PEPFAR supported facilities. CDC results contributed to 72 percent of national VL tests. In FY22, CDC supported 353,945 HIV tests, with 7,729 individuals with HIV were identified (yield 2.2 percent). In addition, linkage to ART was 109 percent (8,447).
TB and HIV
TB continues to be the leading cause of mortality for PLHIV. CDC works with the national TB program and other stakeholders to improve collaboration between TB and HIV programs. In FY2022, all PLHIV on ART in CDC supported facilities were screened for TB. Of the 212 TB cases identified, 98 percent received TB treatment.
HIV surveys
CDC supported six rounds of antenatal clinic (ANC) sentinel surveys (2007, 2009, 2012, 2017, 2020, 2021, and 2022). These surveys provided important data for HIV estimates using the UNAIDS Spectrum Model. CDC also supported bio-behavioral surveys of female sex workers in Juba (2016), Nimule (2017), Wau (2019), and Yambio (2019). These data are used in service delivery policy and funding decisions.
PEPFAR Five-Year Strategy
CDC support to MOH aligns with PEPFAR’s strategy focusing on priority populations and saturating high disease burden regions with HIV services. Through stronger partnerships, CDC will support building sustainable laboratory and health information systems and establishing a functional National Public Health Institute. CDC will also focus on building local capacity to deliver quality HIV services.
Resources
Support for CDC's global HIV and TB efforts.
Our success is built on the backbone of science and strong partnerships.